Document 0341 DOCN M9590341 TI Novel vaccine strategies using fowlpox viruses and plasmid DNA. DT 9509 AU Leong KH; Ramsay AJ; Boyle DB; Robinson HL; Ramshaw IA; Viral Engineering and Cytokine Research Group, JCSMR, Canberra. SO Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:156 (unnumbered abstract). Unique Identifier : AIDSLINE ASHM6/95291758 AB We have studied avipox viruses encoding cytokine genes, both alone and in combination with naked DNA plasmids, as potential vaccine strategies. As these viruses abortively infect mammalian cells, yet still effectively present foreign genes to the immune system, they offer a safer but effective alternative to other live vectors. We have examined the effect of co-expressing the cytokines interleukin-6 (IL-6) or interferon-gamma (IFN gamma) on immune responses to fowlpox virus (FPV) expressing influenza hemagglutinin (HA) as a vaccine antigen. IL-6 augmented antibody responses while IFN gamma inhibited these responses without affecting the generation of cell-mediated immunity. The safety of these constructs was demonstrated in immunodeficient mice and no side effects were observed due to cytokine expression. Direct injection of DNA plasmids encoding foreign genes as a means of vaccination is a subject of great current interest. We have combined this approach with fowlpox vectors, both expressing common HA antigen, to examine the effects of priming with the former intramuscularly and boosting with recombinant FPV. With this combination, both systemic and mucosal antibody responses, respectively, were greatly elevated after boosting at the relevant site. Levels of systemic antibody achieved using this strategy approximated those in convalescent serum. In summary, FPV vectors encoding cytokines represent a safe and effective vaccine strategy which may be used to selectively manipulate the immune response. Greatly enhanced immune responses can be generated when this approach is used in combination with naked DNA immunisation. These findings have implications for the development of improved vaccination strategies. DE AIDS Vaccines/*IMMUNOLOGY Cell Line Fowlpox Virus/*IMMUNOLOGY Hemagglutinins, Viral/IMMUNOLOGY Human HIV/*IMMUNOLOGY Interferon Type II/BIOSYNTHESIS Interleukin-6/BIOSYNTHESIS Plasmids/*IMMUNOLOGY Vaccines, Synthetic/*IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).